Surgical outcomes for older patients with glioblastoma multiforme: Preoperative factors associated with decreased survival

Kaisorn L. Chaichana, Khan K. Chaichana, Alessandro Olivi, Jon D. Weingart, Richard Bennett, Henry Brem, Alfredo Quinones-Hinojosa

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Object. As the population ages, the incidence of glioblastoma multiforme (GBM) among older patients (age > 65 years) will increase. Older patients, unlike their younger counterparts, are not often offered aggressive surgery because of their age, comorbidities, and potential inability to tolerate surgery. The goal of this study was to identify preoperative factors associated with decreased survival for older patients who underwent resection of a GBM. The identification of these factors may provide insight into which patients would benefit most from aggressive surgery. Methods. All patients older than 65 years who underwent nonbiopsy resection of an intracranial GBM at a single institution between 1997 and 2007 were retrospectively reviewed. Factors associated with overall survival were assessed using multivariate proportional hazards regression analysis after controlling for peri- and postoperative factors known to be associated with outcome (extent of resection, carmustine wafer implantation, temozolomide chemotherapy, and radiation therapy). Variables with p < 0.05 were considered statistically significant. Results. A total of 129 patients with an average age of 73 ± 5 years met the inclusion/exclusion criteria. At last follow-up, all 129 patients had died, with a median survival of 7.9 months. The preoperative factors that were independently associated with decreased survival were Karnofsky Performance Scale (KPS) score less than 80 (p = 0.001), chronic obstructive pulmonary disease (p = 0.01), motor deficit (p = 0.01), language deficit (p = 0.005), cognitive deficit (p = 0.02), and tumor size larger than 4 cm (p = 0.002). Patients with 0-1 (Group 1), 2-3 (Group 2), and 4-6 (Group 3) of these factors had statistically different survival times, where the median survival was 9.2, 5.5, and 4.4 months, respectively. In log-rank analysis, the median survival for Group 1 was significantly longer than that for Group 2 (p = 0.004) and Group 3 (p < 0.0001), while Group 2 had longer survival than Group 3 (p = 0.02). Conclusions. Older patients with an increasing number of these factors may not benefit as much from aggressive surgery as patients with fewer factors. This may provide insight into identifying which patients older than 65 years of age may benefit from aggressive surgery.

Original languageEnglish (US)
Pages (from-to)587-594
Number of pages8
JournalJournal of Neurosurgery
Volume114
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Glioblastoma
Survival
temozolomide
Karnofsky Performance Status
Carmustine
Chronic Obstructive Pulmonary Disease
Comorbidity
Language
Radiotherapy
Regression Analysis
Drug Therapy

Keywords

  • Elderly patient
  • Function
  • Glioblastoma
  • Glioblastoma multiforme
  • Survival

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)
  • Clinical Neurology

Cite this

Surgical outcomes for older patients with glioblastoma multiforme : Preoperative factors associated with decreased survival. / Chaichana, Kaisorn L.; Chaichana, Khan K.; Olivi, Alessandro; Weingart, Jon D.; Bennett, Richard; Brem, Henry; Quinones-Hinojosa, Alfredo.

In: Journal of Neurosurgery, Vol. 114, No. 3, 03.2011, p. 587-594.

Research output: Contribution to journalArticle

Chaichana, Kaisorn L. ; Chaichana, Khan K. ; Olivi, Alessandro ; Weingart, Jon D. ; Bennett, Richard ; Brem, Henry ; Quinones-Hinojosa, Alfredo. / Surgical outcomes for older patients with glioblastoma multiforme : Preoperative factors associated with decreased survival. In: Journal of Neurosurgery. 2011 ; Vol. 114, No. 3. pp. 587-594.
@article{b988694e0943405fb85337fadd855786,
title = "Surgical outcomes for older patients with glioblastoma multiforme: Preoperative factors associated with decreased survival",
abstract = "Object. As the population ages, the incidence of glioblastoma multiforme (GBM) among older patients (age > 65 years) will increase. Older patients, unlike their younger counterparts, are not often offered aggressive surgery because of their age, comorbidities, and potential inability to tolerate surgery. The goal of this study was to identify preoperative factors associated with decreased survival for older patients who underwent resection of a GBM. The identification of these factors may provide insight into which patients would benefit most from aggressive surgery. Methods. All patients older than 65 years who underwent nonbiopsy resection of an intracranial GBM at a single institution between 1997 and 2007 were retrospectively reviewed. Factors associated with overall survival were assessed using multivariate proportional hazards regression analysis after controlling for peri- and postoperative factors known to be associated with outcome (extent of resection, carmustine wafer implantation, temozolomide chemotherapy, and radiation therapy). Variables with p < 0.05 were considered statistically significant. Results. A total of 129 patients with an average age of 73 ± 5 years met the inclusion/exclusion criteria. At last follow-up, all 129 patients had died, with a median survival of 7.9 months. The preoperative factors that were independently associated with decreased survival were Karnofsky Performance Scale (KPS) score less than 80 (p = 0.001), chronic obstructive pulmonary disease (p = 0.01), motor deficit (p = 0.01), language deficit (p = 0.005), cognitive deficit (p = 0.02), and tumor size larger than 4 cm (p = 0.002). Patients with 0-1 (Group 1), 2-3 (Group 2), and 4-6 (Group 3) of these factors had statistically different survival times, where the median survival was 9.2, 5.5, and 4.4 months, respectively. In log-rank analysis, the median survival for Group 1 was significantly longer than that for Group 2 (p = 0.004) and Group 3 (p < 0.0001), while Group 2 had longer survival than Group 3 (p = 0.02). Conclusions. Older patients with an increasing number of these factors may not benefit as much from aggressive surgery as patients with fewer factors. This may provide insight into identifying which patients older than 65 years of age may benefit from aggressive surgery.",
keywords = "Elderly patient, Function, Glioblastoma, Glioblastoma multiforme, Survival",
author = "Chaichana, {Kaisorn L.} and Chaichana, {Khan K.} and Alessandro Olivi and Weingart, {Jon D.} and Richard Bennett and Henry Brem and Alfredo Quinones-Hinojosa",
year = "2011",
month = "3",
doi = "10.3171/2010.8.JNS1081",
language = "English (US)",
volume = "114",
pages = "587--594",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Surgical outcomes for older patients with glioblastoma multiforme

T2 - Preoperative factors associated with decreased survival

AU - Chaichana, Kaisorn L.

AU - Chaichana, Khan K.

AU - Olivi, Alessandro

AU - Weingart, Jon D.

AU - Bennett, Richard

AU - Brem, Henry

AU - Quinones-Hinojosa, Alfredo

PY - 2011/3

Y1 - 2011/3

N2 - Object. As the population ages, the incidence of glioblastoma multiforme (GBM) among older patients (age > 65 years) will increase. Older patients, unlike their younger counterparts, are not often offered aggressive surgery because of their age, comorbidities, and potential inability to tolerate surgery. The goal of this study was to identify preoperative factors associated with decreased survival for older patients who underwent resection of a GBM. The identification of these factors may provide insight into which patients would benefit most from aggressive surgery. Methods. All patients older than 65 years who underwent nonbiopsy resection of an intracranial GBM at a single institution between 1997 and 2007 were retrospectively reviewed. Factors associated with overall survival were assessed using multivariate proportional hazards regression analysis after controlling for peri- and postoperative factors known to be associated with outcome (extent of resection, carmustine wafer implantation, temozolomide chemotherapy, and radiation therapy). Variables with p < 0.05 were considered statistically significant. Results. A total of 129 patients with an average age of 73 ± 5 years met the inclusion/exclusion criteria. At last follow-up, all 129 patients had died, with a median survival of 7.9 months. The preoperative factors that were independently associated with decreased survival were Karnofsky Performance Scale (KPS) score less than 80 (p = 0.001), chronic obstructive pulmonary disease (p = 0.01), motor deficit (p = 0.01), language deficit (p = 0.005), cognitive deficit (p = 0.02), and tumor size larger than 4 cm (p = 0.002). Patients with 0-1 (Group 1), 2-3 (Group 2), and 4-6 (Group 3) of these factors had statistically different survival times, where the median survival was 9.2, 5.5, and 4.4 months, respectively. In log-rank analysis, the median survival for Group 1 was significantly longer than that for Group 2 (p = 0.004) and Group 3 (p < 0.0001), while Group 2 had longer survival than Group 3 (p = 0.02). Conclusions. Older patients with an increasing number of these factors may not benefit as much from aggressive surgery as patients with fewer factors. This may provide insight into identifying which patients older than 65 years of age may benefit from aggressive surgery.

AB - Object. As the population ages, the incidence of glioblastoma multiforme (GBM) among older patients (age > 65 years) will increase. Older patients, unlike their younger counterparts, are not often offered aggressive surgery because of their age, comorbidities, and potential inability to tolerate surgery. The goal of this study was to identify preoperative factors associated with decreased survival for older patients who underwent resection of a GBM. The identification of these factors may provide insight into which patients would benefit most from aggressive surgery. Methods. All patients older than 65 years who underwent nonbiopsy resection of an intracranial GBM at a single institution between 1997 and 2007 were retrospectively reviewed. Factors associated with overall survival were assessed using multivariate proportional hazards regression analysis after controlling for peri- and postoperative factors known to be associated with outcome (extent of resection, carmustine wafer implantation, temozolomide chemotherapy, and radiation therapy). Variables with p < 0.05 were considered statistically significant. Results. A total of 129 patients with an average age of 73 ± 5 years met the inclusion/exclusion criteria. At last follow-up, all 129 patients had died, with a median survival of 7.9 months. The preoperative factors that were independently associated with decreased survival were Karnofsky Performance Scale (KPS) score less than 80 (p = 0.001), chronic obstructive pulmonary disease (p = 0.01), motor deficit (p = 0.01), language deficit (p = 0.005), cognitive deficit (p = 0.02), and tumor size larger than 4 cm (p = 0.002). Patients with 0-1 (Group 1), 2-3 (Group 2), and 4-6 (Group 3) of these factors had statistically different survival times, where the median survival was 9.2, 5.5, and 4.4 months, respectively. In log-rank analysis, the median survival for Group 1 was significantly longer than that for Group 2 (p = 0.004) and Group 3 (p < 0.0001), while Group 2 had longer survival than Group 3 (p = 0.02). Conclusions. Older patients with an increasing number of these factors may not benefit as much from aggressive surgery as patients with fewer factors. This may provide insight into identifying which patients older than 65 years of age may benefit from aggressive surgery.

KW - Elderly patient

KW - Function

KW - Glioblastoma

KW - Glioblastoma multiforme

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=79952262306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952262306&partnerID=8YFLogxK

U2 - 10.3171/2010.8.JNS1081

DO - 10.3171/2010.8.JNS1081

M3 - Article

C2 - 20887095

AN - SCOPUS:79952262306

VL - 114

SP - 587

EP - 594

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -